Exact Mass: 467.0604

Exact Mass Matches: 467.0604

Found 50 metabolites which its exact mass value is equals to given mass value 467.0604, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

AG 2034

L-Glutamic acid, N-((5-(2-((6S)-2-amino-4,6,7,8-tetrahydro-4-oxo-1H-pyrimido(5,4-b)(1,4)thiazin-6-yl)ethyl)-2-thienyl)carbonyl)-

C18H21N5O6S2 (467.0933)


   

4-hydroxybenzoyl-AMP

4-Hydroxybenzoyl-adenylate; 4-Hydroxybenzoyl-AMP

C17H18N5O9P (467.0842)


   

2-hydroxybenzoyl-AMP

2-hydroxybenzoyl-AMP

C17H18N5O9P (467.0842)


   

(2S)-2-[[5-[2-[(6S)-2-Amino-4-oxo-1,6,7,8-tetrahydropyrimido[5,4-b][1,4]thiazin-6-yl]ethyl]thiophene-2-carbonyl]amino]pentanedioic acid

(2S)-2-[[5-[2-[(6S)-2-Amino-4-oxo-1,6,7,8-tetrahydropyrimido[5,4-b][1,4]thiazin-6-yl]ethyl]thiophene-2-carbonyl]amino]pentanedioic acid

C18H21N5O6S2 (467.0933)


   

FK-614

1-[(2,4-dichlorophenyl)methyl]-2-methyl-N-(pentane-1-sulfonyl)-1H-1,3-benzodiazole-6-carboxamide

C21H23Cl2N3O3S (467.0837)


   

Fosfadecin

Fosfadecin

C13H19N5O10P2 (467.0607)


   

2-(Benzoyloxy)ethyl glucosinolate

2-(Benzoyloxy)ethyl glucosinolate

C16H21NO11S2 (467.0556)


   

3-Hydroxy-5-(methylsulfinyl)pentyl glucosinolate

3-Hydroxy-5-(methylsulfinyl)pentyl glucosinolate

C13H25NO11S3 (467.059)


   

5-(Methylsufinyl)pentyl glucosinolate

5-(Methylsufinyl)pentyl glucosinolate

C13H25NO11S3 (467.059)


   

Dysideaproline F

Dysideaproline F

C19H28Cl3N3O2S (467.0968)


   

Oprea1_874347

Oprea1_874347

C22H21N5OS3 (467.0908)


   

CCG-48785

CCG-48785

C24H22ClN3O3S (467.107)


   

4-(3-Chloro-2-cyanophenoxy)-N-(4-piperidinophenyl)benzenesulfonamide

4-(3-Chloro-2-cyanophenoxy)-N-(4-piperidinophenyl)benzenesulfonamide

C24H22ClN3O3S (467.107)


   

(-)-homoseongomycin

(-)-homoseongomycin

C24H21NO7S (467.1039)


   

iodide ionophore i

iodide ionophore i

C25H22ClNO4S (467.0958)


   

3-[[4-(2,4,6-trinitroanilino)benzoyl]amino]benzoic acid

3-[[4-(2,4,6-trinitroanilino)benzoyl]amino]benzoic acid

C20H13N5O9 (467.0713)


   

SAMARIUM(III) ACETYLACETONATE HYDRATE

SAMARIUM(III) ACETYLACETONATE HYDRATE

C15H23O7Sm (467.0641)


   

2 6-DICHLORO-4-(2 4 6-TRIPHENYL-1-PYRI-&

2 6-DICHLORO-4-(2 4 6-TRIPHENYL-1-PYRI-&

C29H19Cl2NO (467.0844)


   

disodium,3-[4-[(5-nitropyridin-2-yl)diazenyl]-3-oxido-N-propylanilino]propane-1-sulfonate

disodium,3-[4-[(5-nitropyridin-2-yl)diazenyl]-3-oxido-N-propylanilino]propane-1-sulfonate

C17H19N5Na2O6S (467.0851)


   

(5AS, 10BR)-(-)-5A,10B-DIHYDRO-2-(PENTAFLUOROPHENYL)-4H,6H-INDENO[2,1-B][1,2,4]TRIZOLO[4,3-D][1,4]OXAZINIUM TETRAFLUOROBORATE

(5AS, 10BR)-(-)-5A,10B-DIHYDRO-2-(PENTAFLUOROPHENYL)-4H,6H-INDENO[2,1-B][1,2,4]TRIZOLO[4,3-D][1,4]OXAZINIUM TETRAFLUOROBORATE

C18H11BF9N3O (467.0851)


   

dimethyl 2-[[1-(4-chlorobenzoyl)-2-(trifluoromethyl)indol-3-yl]methyl]propanedioate

dimethyl 2-[[1-(4-chlorobenzoyl)-2-(trifluoromethyl)indol-3-yl]methyl]propanedioate

C22H17ClF3NO5 (467.0747)


   

2-Pentafluorophenyl-6,10b-dihydro-4H,5aH-5-oxo-3,10c-diaza-2-azoniacyclopenta[c]fluorine tetrafluoroborate

2-Pentafluorophenyl-6,10b-dihydro-4H,5aH-5-oxo-3,10c-diaza-2-azoniacyclopenta[c]fluorine tetrafluoroborate

C18H11BF9N3O (467.0851)


   

Cefixime Methyl Ester

Cefixime Methyl Ester

C17H17N5O7S2 (467.0569)


   

3-HYDROXY-4-(5-NITROPYRIDYLAZO)PROPYLANI

3-HYDROXY-4-(5-NITROPYRIDYLAZO)PROPYLANI

C17H19N5Na2O6S1 (467.0851)


   

(S)-Fmoc-phenylalanine-4-sulfonic acid

(S)-Fmoc-phenylalanine-4-sulfonic acid

C24H21NO7S (467.1039)


   

1-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-1H-benzo[d]imidazole-6-carboxamide

1-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-1H-benzo[d]imidazole-6-carboxamide

C21H23Cl2N3O3S (467.0837)


FK614 is an orally active, non-thiazolidinedione (TZD) type, and selective PPARγ modulator (SPPARM). FK614 functions as a PPARγ agonist with potent anti-diabetic activity in vivo. FK614 has different effects on the activation of PPARγ at each stage of adipocyte differentiation. FK614 can be used for the research of hyperglycemia, hypertriglyceridemia, glucose intolerance and type 2 diabetes[1][2].

   

2-(6-Chloro-3-{[2,2-difluoro-2-(1-oxido-2-pyridinyl)ethyl]amino}-2-oxo-1(2H)-pyrazinyl)-N-[(2-fluorophenyl)methyl]acetamide

2-(6-Chloro-3-{[2,2-difluoro-2-(1-oxido-2-pyridinyl)ethyl]amino}-2-oxo-1(2H)-pyrazinyl)-N-[(2-fluorophenyl)methyl]acetamide

C20H17ClF3N5O3 (467.0972)


   

N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide

N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide

C23H18FN3O3S2 (467.0774)


   

N-(1,3-benzodioxol-5-yl)-2-[[6-methyl-4-oxo-3-(phenylmethyl)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]acetamide

N-(1,3-benzodioxol-5-yl)-2-[[6-methyl-4-oxo-3-(phenylmethyl)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]acetamide

C23H21N3O4S2 (467.0973)


   

2-Acetyl-thiamine diphosphate

2-Acetyl-thiamine diphosphate

C14H21N4O8P2S+ (467.0555)


   

2-[[5-[2-(2-Amino-4-oxo-3,6,7,8-tetrahydropyrimido[5,4-b][1,4]thiazin-6-yl)ethyl]thiophene-2-carbonyl]amino]pentanedioic acid

2-[[5-[2-(2-Amino-4-oxo-3,6,7,8-tetrahydropyrimido[5,4-b][1,4]thiazin-6-yl)ethyl]thiophene-2-carbonyl]amino]pentanedioic acid

C18H21N5O6S2 (467.0933)


   

8-Demethyl-8-formylriboflavin 5-phosphate

8-Demethyl-8-formylriboflavin 5-phosphate

C17H16N4O10P-3 (467.0604)


   

2-(3-Hydroxymercurio-2-methoxypropylcarbamoyl)phenoxyacetic acid

2-(3-Hydroxymercurio-2-methoxypropylcarbamoyl)phenoxyacetic acid

C13H15HgNO5- (467.0656)


   

5-[[4-(4-acetylphenyl)-1-piperazinyl]sulfonyl]-3,3-dichloro-1H-indol-2-one

5-[[4-(4-acetylphenyl)-1-piperazinyl]sulfonyl]-3,3-dichloro-1H-indol-2-one

C20H19Cl2N3O4S (467.0473)


   

2-[[5-[[2-(3-Chloroanilino)-4-thiazolyl]methyl]-4-(3-methoxypropyl)-1,2,4-triazol-3-yl]thio]acetic acid methyl ester

2-[[5-[[2-(3-Chloroanilino)-4-thiazolyl]methyl]-4-(3-methoxypropyl)-1,2,4-triazol-3-yl]thio]acetic acid methyl ester

C19H22ClN5O3S2 (467.0853)


   

3-Bromo-5-[[4-[hydroxy(diphenyl)methyl]-1-piperidinyl]-oxomethyl]-2-pyranone

3-Bromo-5-[[4-[hydroxy(diphenyl)methyl]-1-piperidinyl]-oxomethyl]-2-pyranone

C24H22BrNO4 (467.0732)


   

3-[4-(4-Morpholinylsulfonyl)phenyl]propanoic acid [2-[(5-chloro-2-pyridinyl)amino]-2-oxoethyl] ester

3-[4-(4-Morpholinylsulfonyl)phenyl]propanoic acid [2-[(5-chloro-2-pyridinyl)amino]-2-oxoethyl] ester

C20H22ClN3O6S (467.0918)


   

5-[(3-Carboxylato-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)(2-sulfonatophenyl)methyl]-2-hydroxy-3-methylbenzoate

5-[(3-Carboxylato-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)(2-sulfonatophenyl)methyl]-2-hydroxy-3-methylbenzoate

C23H15O9S-3 (467.0437)


   

Cromoglycate(1-)

Cromoglycate(1-)

C23H15O11- (467.0614)


   

3-O-salicyl-AMP

3-O-salicyl-AMP

C17H18N5O9P (467.0842)


   

Sulfoacetyladenylate

Sulfoacetyladenylate

C12H14N5O11PS-2 (467.0148)


   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-hydroxybenzoate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-hydroxybenzoate

C17H18N5O9P (467.0842)


   

L-Glutamic acid, N-((5-(2-((6S)-2-amino-4,6,7,8-tetrahydro-4-oxo-1H-pyrimido(5,4-b)(1,4)thiazin-6-yl)ethyl)-2-thienyl)carbonyl)-

L-Glutamic acid, N-((5-(2-((6S)-2-amino-4,6,7,8-tetrahydro-4-oxo-1H-pyrimido(5,4-b)(1,4)thiazin-6-yl)ethyl)-2-thienyl)carbonyl)-

C18H21N5O6S2 (467.0933)


   

Lp-PLA2-IN-3

Lp-PLA2-IN-3

C20H13ClF3N3O3S (467.0318)


Lp-PLA2-IN-3 is a potent and orally bioavailable lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, with an IC50 of 14 nM for recombinant human Lp-PLA2 (rhLpPLA2)[1].

   

(2r)-3-({2-ethyl-4,5,9-trihydroxy-10-oxobenzo[b]fluoren-11-yl}sulfanyl)-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-({2-ethyl-4,5,9-trihydroxy-10-oxobenzo[b]fluoren-11-yl}sulfanyl)-2-[(1-hydroxyethylidene)amino]propanoic acid

C24H21NO7S (467.1039)


   

4,4-dichloro-n-{5-chloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-n,3-dimethylbutanamide

4,4-dichloro-n-{5-chloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-n,3-dimethylbutanamide

C19H28Cl3N3O2S (467.0968)


   

12-bromo-6-hydroxy-4-(1h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

12-bromo-6-hydroxy-4-(1h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H22BrN5O2 (467.0957)


   

(4e,7s,9r)-12-bromo-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(4e,7s,9r)-12-bromo-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H22BrN5O2 (467.0957)


   

{[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(3-methyloxiran-2-yl)phosphinic acid

{[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(3-methyloxiran-2-yl)phosphinic acid

C13H19N5O10P2 (467.0607)


   

[(z)-(6-methanesulfonyl-1-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hexylidene)amino]oxysulfonic acid

[(z)-(6-methanesulfonyl-1-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hexylidene)amino]oxysulfonic acid

C13H25NO11S3 (467.059)